FDA approves a prefilled syringe format for Purified Cortrophin Gel, reducing administration steps for patients with inflammatory and autoimmune conditions.
Researchers found intravenous secukinumab improved axial spondyloarthritis outcomes vs placebo, with sustained efficacy and a consistent safety profile.